Ravetch, Jeffrey V.

Fcγ receptors as regulators of immune responses

Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology

Monoclonal and Polyclonal Antibodies ResearchT-cell and B-cell Immunology

Cited by 2,947

Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets

Clynes, R. A., Towers, T. L., Presta, L. G., & Ravetch, J. V. (2000) · Nature Medicine

Monoclonal and Polyclonal Antibodies ResearchImmune Cell Function and Interaction

Cited by 2,768

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science

Monoclonal and Polyclonal Antibodies ResearchGlycosylation and Glycoproteins Research

Cited by 1,754

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

Simpson, T. R., Li, F., Montalvo-Ortiz, W., Sepulveda, M. A., Bergerhoff, K., Arce, F., Roddie, C., Henry, J. Y., Yagita, H., Wolchok, J. D., et al. (2013) · Journal of Experimental Medicine

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 1,472

Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc

Anthony, R. M., Nimmerjahn, F., Ashline, D. J., Reinhold, V. N., Paulson, J. C., & Ravetch, J. V. (2008) · Science

Monoclonal and Polyclonal Antibodies ResearchGlycosylation and Glycoproteins Research

Cited by 849

Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo

DiLillo, D. J., Tan, G. S., Palese, P., & Ravetch, J. V. (2014) · Nature Medicine

Influenza Virus Research StudiesMonoclonal and Polyclonal Antibodies Research

Cited by 749

Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis

Georgoudaki, A.-M., Prokopec, K. E., Boura, V. F., Hellqvist, E., Sohn, S., Östling, J., Dahan, R., Harris, R. A., Rantalainen, M., Klevebring, D., et al. (2016) · Cell Reports

Immune cells in cancerCancer Immunotherapy and Biomarkers

Cited by 609

Fc receptors are required in passive and active immunity to melanoma

Clynes, R., Takechi, Y., Moroi, Y., Houghton, A., & Ravetch, J. V. (1998) · Proceedings of the National Academy of Sciences

Monoclonal and Polyclonal Antibodies ResearchImmunotherapy and Immune Responses

Cited by 321

Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo

Schäfer, A., Muecksch, F., Lorenzi, J. C. C., Leist, S. R., Cipolla, M., Bournazos, S., Schmidt, F., Maison, R. M., Gazumyan, A., Martinez, D. R., et al. (2021) · Journal of Experimental Medicine

SARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies Research

Cited by 305

Engineered ACE2 receptor traps potently neutralize SARS-CoV-2

Glasgow, A., Glasgow, J., Limonta, D., Solomon, P., Lui, I., Zhang, Y., Nix, M. A., Rettko, N. J., Zha, S., Yamin, R., et al. (2020) · Proceedings of the National Academy of Sciences

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches

Cited by 251

The role and function of Fcγ receptors on myeloid cells

Bournazos, S., Wang, T. T., & Ravetch, J. V. (2016) · Microbiology Spectrum

Monoclonal and Polyclonal Antibodies ResearchImmune Response and Inflammation

Cited by 138

PU.1 and an HLH family member contribute to the myeloid‐specific transcription of the Fc gamma RIIIA promoter.

Feinman, R., Qiu, W. Q., Pearse, R. N., Nikolajczyk, B. S., Sen, R., Sheffery, M., & Ravetch, J. V. (1994) · The EMBO Journal

Genomics and Chromatin DynamicsMonoclonal and Polyclonal Antibodies Research

Cited by 88